Loading...
Merck & Co., Inc.
6MK.DE•XETRA
HealthcareDrug Manufacturers - General
€70.90
€1.70(2.46%)
Merck & Co., Inc. (6MK.DE) Financial Performance & Statements
Review Merck & Co., Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.74%
↑ 6.74%
Operating Income Growth
668.18%
↑ 668.18%
Net Income Growth
4589.59%
↑ 4589.59%
Operating Cash Flow Growth
65.06%
↑ 65.06%
Operating Margin
31.91%
↑ 31.91%
Gross Margin
76.42%
↑ 76.42%
Net Profit Margin
27.27%
↑ 27.27%
ROE
38.16%
↑ 38.16%
ROIC
22.68%
↑ 22.68%
Merck & Co., Inc. (6MK.DE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Merck & Co., Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $15.62B | $16.66B | $16.11B | $15.78B |
| Cost of Revenue | $924.00M | $4.08B | $3.75B | $3.54B |
| Gross Profit | $14.70B | $12.58B | $12.37B | $12.23B |
| Gross Profit Ratio | $0.94 | $0.76 | $0.77 | $0.78 |
| R&D Expenses | $4.58B | $5.86B | $3.50B | $3.99B |
| SG&A Expenses | $3.30B | $2.73B | $2.74B | $2.48B |
| Operating Expenses | $7.88B | $8.59B | $6.24B | $6.47B |
| Total Costs & Expenses | $8.80B | $12.67B | $9.98B | $10.02B |
| Interest Income | -$269.00M | $127.00M | $69.00M | $73.00M |
| Interest Expense | -$943.00M | $330.00M | $310.00M | $303.00M |
| Depreciation & Amortization | $872.67M | $1.19B | $1.13B | $984.00M |
| EBITDA | $6.93B | $5.61B | $7.45B | $6.96B |
| EBITDA Ratio | $0.44 | $0.34 | $0.46 | $0.44 |
| Operating Income | $6.82B | $3.98B | $6.13B | $5.76B |
| Operating Income Ratio | $0.44 | $0.24 | $0.38 | $0.37 |
| Other Income/Expenses (Net) | -$2.65B | $106.00M | -$122.00M | -$90.00M |
| Income Before Tax | $4.17B | $4.09B | $6.006B | $5.67B |
| Income Before Tax Ratio | $0.27 | $0.25 | $0.37 | $0.36 |
| Income Tax Expense | $426.00M | $929.00M | $545.00M | $903.00M |
| Net Income | $3.74B | $3.16B | $5.46B | $4.76B |
| Net Income Ratio | $0.24 | $0.19 | $0.34 | $0.30 |
| EPS | $1.47 | $1.24 | $2.15 | $1.88 |
| Diluted EPS | $1.49 | $1.24 | $2.14 | $1.87 |
| Weighted Avg Shares Outstanding | $2.54B | $2.55B | $2.53B | $2.53B |
| Weighted Avg Shares Outstanding (Diluted) | $2.54B | $2.54B | $2.54B | $2.54B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan